Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia

Abstract Background Preeclampsia is a unique multisystem disorder that affects 5–8% of pregnancies. A high level of soluble fms-like tyrosine kinase-1 (sFlt-1) is a hallmark of preeclampsia that causes endothelial dysfunction. Exosomes derived from mesenchymal stem cells (MSCs) have been indicated t...

Full description

Bibliographic Details
Published in:	European Journal of Medical Research
Main Authors:	Xinwen Chang, Qizhi He, Mengtian Wei, Linyan Jia, Yingying Wei, Yiding Bian, Tao Duan, Kai Wang
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Subjects:	Preeclampsia Mesenchymal stem cell Exosomes Angiogenesis Soluble fms-like tyrosine kinase-1/sFlt-1
Online Access:	https://doi.org/10.1186/s40001-023-01182-8

Similar Items

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia
by: Teri Wina Herwati, et al.
Published: (2018-04-01)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
by: Anca-Florina Tataru-Copos, et al.
Published: (2022-09-01)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2023-06-01)

Activation of PAR-1/NADPH Oxidase/ROS Signaling Pathways is Crucial for the Thrombin-Induced sFlt-1 Production in Extravillous Trophoblasts: Possible Involvement in the Pathogenesis of Preeclampsia
by: Qi-tao Huang, et al.
Published: (2015-03-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Intraperitoneal Injection of High Tumor Necrosis Factor (TNF- α ) Serum Increase Soluble Fms-like Tyrosine Kinase 1 (sFlt-1) and Blood Pressure of Pregnant Mice
by: Bramantyo Aji Wicaksono, et al.
Published: (2015-05-01)

Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19
by: Salvador Espino-y-Sosa, et al.
Published: (2021-09-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
by: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Published: (2023-05-01)

Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?
by: Majed Alhudhud, et al.
Published: (2024-12-01)

Predictive Value Analysis of Serum sFlt-1 and PLGF Levels/Ratio in Preeclampsia
by: Shuyuan Xue, et al.
Published: (2022-09-01)

The role of sFlt1/PlGF ratio in the assessment of preeclampsia and pregnancy-related hypertensive disorders
by: Jonathan Baert, et al.
Published: (2021-07-01)

MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
by: Lissette Carolina Sanchez-Aranguren, et al.
Published: (2020-07-01)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
by: Na Wang, et al.
Published: (2021-01-01)

Perbandingan Kadar Soluble Fms-Like Tyrosine Kinase 1 (SFLT1) Serum Kehamilan Normal dengan Preeklamsi Berat Serta Hubungannya dengan Tekanan Darah dan Derajat Proteinuria
by: Amillia Siddiq, et al.
Published: (2009-09-01)

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia
by: Ai-ris Yonekura Collier, et al.
Published: (2019-07-01)

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
by: Laura Ehrlich, et al.
Published: (2017-04-01)

Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients
by: Xiaohe Zhu, et al.
Published: (2020-10-01)

Progesterone Induced Blocking Factor Reduces Hypertension and Placental Mitochondrial Dysfunction in Response to sFlt-1 during Pregnancy
by: Evangeline Deer, et al.
Published: (2021-10-01)

Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy
by: Muhammad Ilham Aldika Akbar, et al.
Published: (2018-10-01)

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
by: Lisa Middendorf, et al.
Published: (2022-06-01)

Differences in levelFms-Like Tyrosine Kinase-1 (sFlt-1), soluble Endoglin (s-Eng), and Placental Growth Factor (PIGF) between Early Onset Preeclampsia and Late Onset Preeclampsia
by: Lita Nafratilova, et al.
Published: (2018-10-01)

Impact of parity and pre-pregnancy BMI on second-trimester sFlt-1 and PlGF levels in normotensive pregnancies
by: Motoaki Kinugawa, et al.
Published: (2025-12-01)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
by: Sama Hussein, et al.
Published: (2022-12-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

sFlt-1 Levels as a Predicting Tool in Placental Dysfunction Complications in Multiple Pregnancies
by: Valentina Giardini, et al.
Published: (2023-10-01)

Serum sFlt-1/PlGF ratio combined with ANXA2 correlates with adverse pregnancy outcomes in women with suspected preeclampsia
by: YaNuan Chen, et al.
Published: (2025-12-01)

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
by: Alice Hoeller, et al.
Published: (2017-04-01)

A Second Trimester Prediction Algorithm for Early-Onset Hypertensive Disorders of Pregnancy Occurrence and Severity Based on Soluble fms-like Tyrosine Kinase 1 (sFlt-1)/Placental Growth Factor (PlGF) Ratio and Uterine Doppler Ultrasound in Women at Risk
by: Cristian Nicolae Chirilă, et al.
Published: (2024-04-01)

The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case
by: Valentina Giardini, et al.
Published: (2025-02-01)

THE ROLE OF THE PIGF/SFLT-1 RELATIONSHIP IN PREDICTING PREECLAMPSIA (LITERATURE REVIEW)
by: Irina Venzkovskaya, et al.
Published: (2019-04-01)

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: A historical cohort study
by: Catarina R. Palma dos Reis, et al.
Published: (2023-05-01)

A Case Report of Influence of Free Tyrosine Kinase/Placental Growth Factor (SFLT-1/PLGF) Ratio Test for Preeclampsia on Clinical Decision Making in Screening Positive Women
by: Polina Vasileva, et al.
Published: (2019-12-01)

Distinct phenotypes in the preeclamptic-like mouse model induced by adenovirus carrying sFlt1 and recombinant sFlt1 protein
by: Yingying Wei, et al.
Published: (2024-12-01)

Associations Between Soluble fms‐Like Tyrosine Kinase‐1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia
by: Roxanne Hastie, et al.
Published: (2022-08-01)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
by: Jacek Witwicki, et al.
Published: (2021-08-01)

Suppression of Development of Ankylosing Spondylitis Through Soluble Flt-1
by: Zhongxiang Yu, et al.
Published: (2015-11-01)

Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia
by: Valeria Sandrim, et al.
Published: (2019-04-01)

sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients
by: Kamil Pluta, et al.
Published: (2024-01-01)

Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
by: Isabelle Hernandez, et al.
Published: (2021-02-01)